Global Cord Blood Corporation
CO was delisted on the 23rd of September, 2022.
1 hedge funds and large institutions have $12.8K invested in Global Cord Blood Corporation in 2025 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.
6% less capital invested
Capital invested by funds: $13.7K → $12.8K (-$810)
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LC
Luminist Capital
Grand Rapids,
Michigan
|
-$165 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
RhumbLine Advisers
Boston,
Massachusetts
| $12.7K | – | – | – |
|
|
LC
2
Luminist Capital
Grand Rapids,
Michigan
| $157 | -$165 | -165 | Closed |
|
CO Hedge Fund Activity: Q4 2025 in Review
1 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q4 2025, worth a combined $12.8K — down 5.9% from $13.7K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of CO and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Luminist Capital, exiting entirely with an estimated $165 sold.
- 1 institutional investor held Global Cord Blood Corporation (CO) as of Q4 2025, down from 2 in Q3 2025.
- Funds reported $12.8K of Global Cord Blood Corporation stock for Q4 2025, down 5.9% quarter-over-quarter.
- 0 funds opened new Global Cord Blood Corporation positions in Q4 2025 and 1 closed out, a net change of -1 holder.
- The largest Global Cord Blood Corporation seller in Q4 2025 was Luminist Capital, an estimated $165 sold.
Based on aggregated 13F filings for Q4 2025.